Search
Showing results for "Au"
News & Events
Trans Pathways researcher recognised as one of Australia’s Tomorrow MakersYouth mental health researcher Penelope Strauss has been named an AMP Tomorrow Maker – the first researcher from The Kids Research Institute Australia to win one of the annual AMP Foundation grants.
News & Events
An open letter to WA familiesMy colleagues and I at Perth's The Kids Research Institute Australia study how to make current vaccines work better, reduce common side effects, and develop new vaccines.
News & Events
The Kids Research Institute Australia Open DayFriends and supporters of The Kids Research Institute Australia are invited to join us to celebrate 25 years of making a difference to kids' health at our Open Day.
News & Events
Watch out Super Nanny - Australian parents are doing it for themselves!The first large scale scientific evaluation of group-based positive parenting programs has found that the intervention reduces behavioural problems
Research
Colostrum, the missing link for healthy growthValerie Verhasselt MD, PhD Head, Immunology and Breastfeeding 0402997617 Valerie.verhasselt@thekids.org.au Head, Immunology and Breastfeeding @
Research
Developing a human challenge model of GAS infectionJonathan Carapetis AM AM MBBS FRACP FAFPHM PhD FAHMS Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@
Research
Electronic Use in Little Ones (EUiLO)Mary Brushe BPsych(Hons), PhD (Public Health) Senior Research Officer, Epidemiology mary.brushe@thekids.org.au Senior Research Officer, Epidemiology
Research
Sport in First-episode PsychosisYael Perry BPsych (Hons) MPsych (Clin) PhD Program Head, Mental Health & Youth; Head, Youth Mental Health 08 6319 1298 yael.perry@thekids.org.au
Research
The NICE GUT TrialTom Snelling BMBS DTMH GDipClinEpid PhD FRACP Head, Infectious Disease Implementation Research 08 6319 1817 tom.snelling@thekids.org.au Head,
Research
Lytic activity, stability, biofilm disruption capabilities and genomic characterisation of two bacteriophages active against respiratory MRSAThis study aimed to characterise bacteriophages for potential therapeutic use against Staphylococcus aureus, focusing on clinical respiratory isolates of methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) strains. Specifically, it sought to evaluate phage lytic activity, host range, stability, biofilm disruption capabilities, and overall safety for therapeutic use.